𝔖 Bobbio Scriptorium
✦   LIBER   ✦

901 SRD5A1 and SRD5A2 genes are associated with the treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic-receptor antagonist

✍ Scribed by Gu, X.; Na, R.; Li, W.; Tao, S.; Tian, L.; Chen, Z.; Jiao, Y.; Kang, J.; Zheng, S.; Xu, J.; Sun, J.; Qi, J.


Book ID
122456921
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
83 KB
Volume
12
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES